Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jul 6;9(7):63. doi: 10.1038/s41389-020-00249-z

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 5 — a Transwell migration and Matrigel invasion assays for GC cells treated with conditioned medium of untreated (0-NCM) and CXCL5 (100 nM)-treated (100-NCM) neutrophils. b Western blot assays for the expression of EMT markers in GC cells treated with conditioned medium of untreated and CXCL5-treated neutrophils. c Transwell migration and Matrigel invasion assays for GC cells treated with conditioned medium of untreated (NCM) or TTCM-primed neutrophils (TNCM) in the presence or absence of CXCL5 neutralizing antibody. d ELISA assays for IL-6 and IL-23 concentrations in culture supernatants from CXCL5-primed neutrophils. e Transwell migration and Matrigel invasion assays for GC cells treated with conditioned medium of CXCL5-activated neutrophils in the presence or absence of IL-6 and IL-23 neutralizing antibodies. f Western blot assays for the expression of EMT markers in GC cells treated with conditioned medium of CXCL5-activated neutrophils in the presence or absence of IL-6 and IL-23 neutralizing antibodies.